-
biochemical and ADME/PK studies and data analysis Generating SAR hypotheses Performing empirical and structure-based target design Executing synthetic chemistry and troubleshooting Improving the potency
-
, 7nAChR, 9* nAChR, GIRK1/2, GIRK1/4, etc.) Conducting biochemical and ADME/PK studies and data analysis Generating SAR hypotheses Performing empirical and structure-based target design Executing synthetic
-
equity for youth of color and their families using community engaged practices. The CHANGE lab, which is housed in the IHESJR, has areas of focus ranging across individual, community, and structural levels
-
interested in applicants who use advanced quantitative methods, including computational modeling, machine learning, and/or analyzing structural and functional neuroimaging data. Specific activities may include
-
, a7nAChR, a9* nAChR, GIRK1/2, GIRK1/4etc.). Key initial responsibilities will include biochemical and ADME/PK studies and data analysis, SAR hypothesis generation, empirical and structure-based target design
-
, government officials, journalists/media, etc. Comfortable navigating complex internal processes and structures. Respect for the importance of interdisciplinary teams. Entrepreneurial mindset, self-starter and
-
to bring meaningful improvement to patients’ lives. Responsibilities The Medical Affairs fellowship at Zevra Therapeutics provides fellows with a comprehensive introduction to the structure, responsibilities
-
, government officials, journalists/media, etc. Comfortable navigating complex internal processes and structures. Respect for diversity and the importance of interdisciplinary teams. Entrepreneurial mindset
-
opportunities may vary depending on the interests of the PharmD fellow(s) as well as the needs of the department. Overall, the structured program will provide a cumulative set of skills that will help facilitate
-
Company Core Data Sheet (CCDS), US Package Insert (USPI), Summary of Product Characteristics (SmPC), and Structured Product Labeling (SPL). Support development of regulatory labeling strategy and the